GBT is now part of Pfizer! Click here for more information.

OUR commitment

GBT is advancing the care of people with sickle cell disease by developing breakthrough therapies, raising awareness and working to increase access to care

GBT seeks to improve the lives of those with sickle cell disease (SCD) by combining focused science with compassion and collaboration. Our deep commitment to partnering with and advocating for the sickle cell community has been our guiding light since the beginning. First and foremost, we prioritize listening to and understanding the perspectives, interests and challenges patients face so we can develop important new investigational treatments and support access to care. We work with patient communities and healthcare providers to transform the quality of the care provided to people with SCD.

Why we’ve made it a priority to partner with patients and advocates

Patients are our focus. They are the true experts when it comes to knowing the impact of the disease and the challenges they face in receiving care

Patients & Advocacy

Supporting those who share our commitment to the sickle cell community

We provide support and funding for researchers and advocacy groups

Corporate Giving

Learn about the sickle cell disease conferences we support

Learn how stakeholders from across the SCD community share the latest advancements, future trends and ideas for improving patient care

View meeting information

Follow us on social media: